These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1462 related items for PubMed ID: 7559897

  • 1. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [Abstract] [Full Text] [Related]

  • 2. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate.
    Verrotti A, Ferrari M, Sabatino G, Morgese G, Chiarelli F.
    Gynecol Endocrinol; 1997 Aug; 11(4):243-50. PubMed ID: 9272420
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor-I and IGF binding protein-3 remain high after GnRH analogue therapy in girls with central precocious puberty.
    Kanety H, Karasik A, Pariente C, Kauschansky A.
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):7-12. PubMed ID: 8796132
    [Abstract] [Full Text] [Related]

  • 4. Irreversible increase of serum IGF-1 and IGFBP-3 levels in GnRH-dependent precocious puberty of different etiologies: implications for the onset of puberty.
    Belgorosky A, Rivarola MA.
    Horm Res; 1998 Jul; 49(5):226-32. PubMed ID: 9568807
    [Abstract] [Full Text] [Related]

  • 5. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
    Tatò L, Saggese G, Cavallo L, Antoniazzi F, Corrias A, Pasquino AM, Cisternino M.
    Horm Res; 1995 Jul; 44 Suppl 3():49-54. PubMed ID: 8719441
    [Abstract] [Full Text] [Related]

  • 6. Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty.
    Juul A, Flyvbjerg A, Frystyk J, Müller J, Skakkebaek NE.
    Clin Endocrinol (Oxf); 1996 May; 44(5):515-23. PubMed ID: 8762727
    [Abstract] [Full Text] [Related]

  • 7. Suppression of the pituitary-gonadal axis in children with central precocious puberty: effects on growth, growth hormone, insulin-like growth factor-I, and prolactin secretion.
    Sklar CA, Rothenberg S, Blumberg D, Oberfield SE, Levine LS, David R.
    J Clin Endocrinol Metab; 1991 Oct; 73(4):734-8. PubMed ID: 1909701
    [Abstract] [Full Text] [Related]

  • 8. The acid-labile subunit of human ternary insulin-like growth factor-binding protein complex in girls with central precocious puberty before and during gonadotropin-releasing hormone analog therapy.
    Cisternino M, Draghi M, Lauriola S, Scarcella D, Bernasconi S, Cavallo L, De Luca F, Lomeo A, Tatò L.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4629-33. PubMed ID: 12364447
    [Abstract] [Full Text] [Related]

  • 9. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
    Hertel NT, Stoltenberg M, Juul A, Main KM, Müller J, Nielsen CT, Lorenzen I, Skakkebaek NE.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
    [Abstract] [Full Text] [Related]

  • 10. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 in girls with premature thelarche.
    Sales DS, Moreira AC, Camacho-Hübner C, Ricco RG, Daneluzzi JC, Campos AD, Martinelli CE.
    J Pediatr Endocrinol Metab; 2003 Apr; 16(6):827-33. PubMed ID: 12948294
    [Abstract] [Full Text] [Related]

  • 11. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty: influence on growth and predicted final height. The German-Dutch Precocious Puberty Study Group.
    Partsch CJ, Hümmelink R, Peter M, Sippell WG, Oostdijk W, Odink RJ, Drop SL.
    Horm Res; 1993 Apr; 39(3-4):111-7. PubMed ID: 8262471
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center.
    Chung LY, Kang E, Nam HK, Rhie YJ, Lee KH.
    J Korean Med Sci; 2021 Aug 30; 36(34):e219. PubMed ID: 34463062
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M, Chaussain JL, Berlier P, Bost M, Canlorbe P, Colle M, Francois R, Garandeau P, Lahlou N, Morel Y.
    J Clin Endocrinol Metab; 1986 Apr 30; 62(4):670-7. PubMed ID: 2936759
    [Abstract] [Full Text] [Related]

  • 15. Serum inhibin A and inhibin B in central precocious puberty before and during treatment with GnRH agonists.
    Sehested A, Andersson AM, Müller J, Skakkebaek NE.
    Horm Res; 2000 Apr 30; 54(2):84-91. PubMed ID: 11251372
    [Abstract] [Full Text] [Related]

  • 16. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB.
    J Clin Endocrinol Metab; 1999 Jan 30; 84(1):44-9. PubMed ID: 9920060
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM, Pucarelli I, Segni M, Matrunola M, Cerroni F.
    J Clin Endocrinol Metab; 1999 Feb 30; 84(2):449-52. PubMed ID: 10022399
    [Abstract] [Full Text] [Related]

  • 19. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
    Mansfield MJ, Rudlin CR, Crigler JF, Karol KA, Crawford JD, Boepple PA, Crowley WF.
    J Clin Endocrinol Metab; 1988 Jan 30; 66(1):3-9. PubMed ID: 2961786
    [Abstract] [Full Text] [Related]

  • 20. [Comparison between complete and incomplete suppression of the hypophyseal-gonadal axis in girls with central precocious puberty: effect on growth and prospective final height].
    Partsch CJ, Hümmelink R, Sippell WG, Oostdijk W, Odink RJ, Drop SL.
    Monatsschr Kinderheilkd; 1993 Dec 30; 141(12):935-9. PubMed ID: 8114776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.